Teprasiran
Teprasiran Uses, Dosage, Side Effects, Food Interaction and all others data.
Teprasiran is under investigation in clinical trial NCT03510897 (QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery).
| Trade Name | Teprasiran |
| Generic | Teprasiran |
| Teprasiran Other Names | Teprasiran |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Teprasiran
